The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Judy - US: Sympathetic Autonomic Nervous System Disorder, PTSD (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'd like to introduce Judy from the U.S. She was diagnosed with sympathetic autonomic nervous system disorder due to chronic PTSD and trauma. Thanks for joining us today, Judy.
Dr Richard Nahas, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Richard Nahas shares their Low Dose Naltrexone (LDN)
Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health.
Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Benefits Of Taking Low Dose Naltrexone
KHTS HometownStation
23 August 2021
https://www.hometownstation.com/news-articles/benefits-of-taking-low-dose-naltrexone-387863
Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr. Kat Toups is an MD from California in the US, a functional medicine doctor and a psychiatrist.
Dr Jordan Atkinson, LDN Radio Show 12 May 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Jordan Atkinson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Complex Regional Pain Syndrome: A Comprehensive Review
Pain Ther
24 June 2021
https://pubmed.ncbi.nlm.nih.gov/34165690/
Morphine reduced perceived anger from neutral and implicit emotional expressions
Psychoneuroendocrinology
May 2018
https://pubmed.ncbi.nlm.nih.gov/29550675/
Low dose naltrexone in the treatment of dissociative symptoms (article in German)
Nervenarzt
March 2015
https://pubmed.ncbi.nlm.nih.gov/25421416/
Background: Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day).